Medikaloka Hermina PT

HEAL · JK · Healthcare / Medical Care Facilities

494.00IDR+14.00 (+2.92%)

Price History

Full chart

Market Stats

Previous Close480.00

Open480.00

Day Range480.00 – 498.00

52-Week Range575.00 – 1,595.36

Volume12.25M

Market Cap9.15T

P/E (TTM)23.15

Forward P/E18.28

EPS25.92

Dividend Yield2.25%

Beta-0.20

50-Day Avg700.20

200-Day Avg1,046.95

About

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, plastic and reconstructive surgery, neurosurgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, primary care family medicine, nuclear medicine and molecular theranostics, psychiatry, andrology, dietetics, lactation counseling, and dermatology and venereology. It also provides services in the areas of ophthalmology, clinical microbiology, pediatric neurology, occupational, radiation oncology, orthopedics and traumatology, pulmonology, anatomical pathology, clinical pathology, anesthesiology, internal medicine, psychology, radiology, physical medicine and rehabilitation, neurology, sports medicine specialist, aviation specialist, radiation specialist, otorhinolaryngology, occupational therapy, and urology. In addition, the company offers digital subtraction angiography, gastroenterology, IVF clinic, sleep and snoring clinic, pain clinic, growth and development clinic, stem cell, palliative care, perinatology ward, integrated stroke, and medical tourism services. Further, it is involved in investment, service, trading, management consulting, nurse training, and education services. PT Medikaloka Hermina Tbk was founded in 1985 and is headquartered in Jakarta Timur, Indonesia.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEODr. Yulisar Khiat S.E.
Employees19.23K
HeadquartersJalan Raya Jatinegara Barat No. 126, Jakarta Timur, Indonesia, 13320, Indonesia
Websitehttps://www.herminahospitals.com

Leadership

Dr. Yulisar Khiat S.E.President Director · b. 1959
Dr. Tan Suryanti GunadiMD of Operational & General Affairs and Director · b. 1959
Dr. Binsar Parasian SimorangkirMD of Medical and Compliance & Vice President Commissioner · b. 1944
Arie Setyo WahyudiHead of Licensing & Legal
Dr. Muyi Ayoe Hapsari M.M.Head of Marketing
Ms. Susi SetiawatyMD of Human Capital, Corporate Secretary & Director · b. 1964
Ms. Meijani Wibowo B.A., M.B.A.Commissioner · b. 1966
Hastiyudo Wibowo M.B.A.Business Development
Ms. Chatarina Sri Haryanti Marsiyo M.M.Head of Internal Audit · b. 1975
Dr. Iing Ichsan HanafiCorporate Secretary · b. 1969

Financials

Income Statement

Currency: IDR	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.71T	2.23T	2.68T	3.06T	3.63T	4.42T	5.82T	4.90T	5.78T	6.74T	7.13T
Growth (%)	-	+30.73%	+19.87%	+14.18%	+18.73%	+21.62%	+31.80%	-15.78%	+18.00%	+16.47%	+5.89%
Cost of Revenue	970.35B	1.24T	1.51T	1.70T	2.00T	2.28T	2.92T	3.19T	3.96T	4.28T	5.00T
Gross Profit	738.67B	989.50B	1.17T	1.35T	1.63T	2.13T	2.90T	1.71T	1.82T	2.46T	2.14T
Gross Margin	43.22%	44.29%	43.64%	44.26%	44.79%	48.34%	49.75%	34.85%	31.54%	36.45%	29.93%
Operating Expense	525.94B	646.15B	783.30B	967.63B	1.04T	1.09T	1.12T	1.12T	1.04T	1.40T	1.19T
Operating Income	212.73B	343.35B	385.56B	385.97B	583.33B	1.04T	1.78T	587.37B	780.70B	1.06T	941.36B
Operating Margin	12.45%	15.37%	14.40%	12.62%	16.07%	23.59%	30.55%	11.98%	13.50%	15.71%	13.20%
EBITDA	314.58B	463.88B	551.72B	593.70B	841.21B	1.37T	2.22T	1.17T	1.58T	1.35T	1.27T
EBITDA Margin	18.41%	20.76%	20.60%	19.41%	23.17%	31.02%	38.23%	23.96%	27.39%	19.97%	17.84%
Net Income	19.30B	62.00B	97.55B	124.37B	343.92B	645.64B	995.97B	298.60B	437.35B	535.94B	429.55B
Net Income Margin	1.13%	2.77%	3.64%	4.07%	9.47%	14.62%	17.11%	6.09%	7.56%	7.96%	6.02%
Interest Expense	34.43B	67.03B	115.33B	130.69B	108.88B	128.81B	143.20B	139.83B	139.56B	179.10B	238.44B
Interest Expense % of Total Revenue	2.01%	3.00%	4.31%	4.27%	3.00%	2.92%	2.46%	2.85%	2.41%	2.66%	3.34%

Balance Sheet

Currency: IDR	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.78T	2.50T	3.35T	4.17T	5.05T	6.36T	7.59T	7.59T	8.80T	10.58T	11.89T
Total Liabilities	824.54B	1.24T	2.39T	1.80T	2.28T	2.97T	3.20T	2.91T	3.60T	4.71T	4.68T
Total Equity	905.00B	1.19T	454.33B	1.87T	2.15T	2.55T	3.27T	3.44T	3.87T	4.45T	5.68T
Cash	118.82B	203.17B	322.43B	303.80B	593.25B	864.58B	1.29T	774.95B	855.21B	643.17B	727.79B
Total Debt	354.11B	613.76B	1.43T	865.79B	1.29T	1.57T	1.67T	1.74T	2.26T	3.24T	3.23T
Net Debt	235.29B	410.59B	1.11T	561.99B	701.39B	700.87B	380.01B	962.40B	1.41T	2.60T	2.50T

Cash Flow

Currency: IDR	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	255.71B	362.85B	465.08B	241.67B	572.58B	1.13T	1.86T	503.58B	1.32T	1.14T	1.14T
Investing Cash Flow	-451.06B	-454.95B	-1.46T	-880.95B	-605.67B	-1.04T	-1.18T	-1.22T	-1.68T	-2.36T	-1.79T
Financing Cash Flow	170.16B	176.46B	1.12T	620.65B	322.54B	181.02B	-252.92B	-158.60B	438.48B	1.01T	734.16B
Capital Expenditure	452.66B	487.92B	696.31B	764.16B	575.94B	889.65B	1.21T	1.13T	1.59T	2.28T	1.75T
Free Cash Flow	-196.95B	-125.08B	-231.23B	-522.49B	-3.36B	236.83B	642.79B	-625.43B	-271.71B	-1.14T	-612.15B
Dividends Paid	27.37B	36.07B	52.35B	32.70B	32.70B	35.57B	73.52B	86.66B	101.44B	126.56B	155.47B
FCF to OCF	-77.02%	-34.47%	-49.72%	-216.20%	-0.59%	21.02%	34.63%	-124.20%	-20.59%	-100.59%	-53.80%
Dividend Paid to FCF	-13.90%	-28.84%	-22.64%	-6.26%	-972.72%	15.02%	11.44%	-13.86%	-37.34%	-11.06%	-25.40%

Earnings

Report Date	Aug 1, 2018	Oct 31, 2018	Mar 31, 2019	Apr 1, 2019	Jul 29, 2019	Oct 28, 2019	Dec 31, 2019	Apr 6, 2020	Aug 3, 2020	Nov 11, 2020	Dec 31, 2020	May 30, 2021	Jul 31, 2021	Nov 5, 2021	Dec 31, 2021	Apr 1, 2022	Aug 8, 2022	Nov 4, 2022	Dec 31, 2022	Apr 25, 2023	Aug 3, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	2.22	2.70	0.95	3.80	4.59	5.75	3.05	3.05	2.15	10.47	14.28	14.30	17.53	15.30	15.49	15.49	3.68	5.59	3.65	3.66	6.43
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	After-hours	After-hours	After-hours	Pre-market	Pre-market	After-hours	-	After-hours	After-hours	Pre-market	-	After-hours	Pre-market	Pre-market	-	Pre-market	After-hours	After-hours	-	After-hours	After-hours

Key Statistics & Ratios

Market Cap9.15T

Enterprise Value12.82T

Trailing P/E23.15

Forward P/E18.28

PEG Ratio7.95

Price / Sales1.24

Price / Book1.77

EPS25.92

Book Value361.72

Revenue (TTM)7.35T

Gross Profit (TTM)2.31T

EBITDA1.77T

Profit Margin5.41%

Operating Margin11.91%

Return on Equity7.28%

Return on Assets4.89%

Shares Outstanding15.25B

Shares Float7.93B

Beta-0.20

Dividend Yield2.25%

Dividend Rate13.50

Payout Ratio52.10%

Dividends

20261×

13.50May 5, 2026

20251×

10.50May 5, 2025

20241×

8.50May 22, 2024

20231×

7.00Jun 12, 2023

20221×

6.00Jun 7, 2022

20211×

5.00Jun 11, 2021

20201×

2.40Jun 12, 2020

20191×

2.20May 10, 2019

Stock Splits

Jul 30, 20215:1